India’s growth story is being powered by its biggest companies. Learn how tools like the Nifty 50 heat map, stock screeners, ...

Ed Croft, of Stockopedia, explains how to establish rules that will help you pick winning companies and avoid those that turn ...

Reading is a great way to become a better investor. Start your library with our list of the 10 best investing books for ...

LVHI offers high yield, low volatility, and full currency hedging, but comes with trade-offs like fluctuating dividends and ...

AVSD is a unique mix of ESG screening and factor investing in developed ex-US markets. Read more on AVSD offering competitive ...

Key Points Time in the market beats market timing in the long run. The "sell in May" strategy has been helpful in less than ...

Key Takeaways DeepSeek merges technical, fundamental, and sentiment data for holistic market insights.Retail investors now ...

Instinct alone is not enough. The best investors in 2025 are no longer relying on gut feelings, social media hype, or vague ...

He is also a contributing Stock Analyst for The Motley Fool’s Rule Breakers premium investing service. Rick has been a contributor with The Motley Fool for 30 years.

Founded in 1998, Genmab develops customised antibodies for use in cancer treatments. Historically, the group has licensed its technology and the commercialisation of its drugs to large pharma giants ...

IBM, Chipotle, and American Airlines just served up “crooked numbers” that wiped 8‑12 % off their share prices before ...